In a regulatory filing, Janus Henderson disclosed an 11.9% stake in athenahealth and said that, on May 15, 2018, it engaged the company’s board of directors to express, among other things, that it believes initiating a formal sale process for the company is in the best interest of the its shareholders. Janus also expressed concerns over management’s execution of strategic initiatives. As such, Janus expressed its view that it is in the best interest of athenahealth’s shareholders to engage with third parties making offers for the company, and to open up a broader sales process.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.